Biokin Pharmaceutical Selects Cryoport's Temperature-Controlled Solutions for its Pending Phase I and Phase II trials

Stock Information for CryoPort Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CryoPort Inc.

Cryoport Expands into Biostorage through the Acquisition of Cryogene
Cryoport to Host Workshop at 14th Annual World Advanced Therapies & Regenerative Medicine Congress on Wednesday, May 15th
Cryoport Revenue Grows 65% for First Quarter 2019
Cryoport to Report First Quarter 2019 Financial Results on May 2nd, 2019
Celularity Selects Cryoport's Temperature Controlled Logistics Solutions
Cryoport Reports 64% Growth for Fiscal Year 2018
Cryoport to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7th, 2019
Cryoport Opens Global Logistics Center in Amsterdam

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.